TABLE 7.
Summary of selected studies highlighting the role of EGFR signalling in renal fibrosis.
| Number | Model | Methodology | Findings/Results/Conclusion relevant to EGFR | Study Reference |
|---|---|---|---|---|
| 1 | Mouse models and Human CKD patients | Unilateral ureteral obstruction induced renal fibrosis in T1D and T2D nephropathies | Significant increase in HER2 | Li, H et al. (2019) |
| 2 | Mice model | Erlotinib action on CKD rats with remnant kidney | Inhibiting Akt and ERK 1/2 signaling resulted in reduced levels of cortical profibrogenic genes along with glomerulosclerosis and tubulointerstitial damage | Yamamoto et al. (2018) |
| 3 | Murine model | EGFR mimotope in unilateral ureteral obstruction | Improved renal fibrosis, decreased expression of collagen I, fibronectin and α-SMA | Yang et al. (2019) |
| 4 | Mice model | Ang II-stimulated mice treated with EGFR inhibitor 453 | Inhibition of AKT and ERK pathways 453 also inhibited the activation of fibrotic pathways such as collagen, CFGF, TGF-β |
Skibba et al. (2016) |
| 5 | Mice model | Usage of short hairpin RNA knockdown to inhibit the activation of EGFR in Angiotensin II-treated SV40 mesangial cells | Abolished buildup of fibrotic markers including CTGF and collagen IV | Qian et al. (2016) |
| 6 | Mice model | PAR2 activation in kidney tubular epithelial cells | Enhancement of Smad2 activation and release of pro-fibrotic factors via transactivation of EGF and TGFβ | Chung et al. (2013) |
| 7 | Murine model | Erlotinib treated aldosterone-mediated tissue fibrosis mice | TGF-β, α-SMA, and mesangial matrix proteins including collagen Ⅳ and fibronectin had inhibited expression | Sheng et al. (2016) |
| 8 | Mouse model | EGFR activation by expressing EGFR ligand hHB-EGF | Evolvement of progressive renal tubulointerstitial fibrosis | Overstreet et al. (2017) |
| 9 | Human HK-2 cell line | Incrementing concentrations of albumin on fibrosis indicators and mediators in models with and without γ-secretase inhibitor | EGFR has a major role in albumin-induced fibrotic events via halting γ-secretase activity | Slattery et al. (2013) |
| 10 | Murine model | PP1 treating cultured renal interstitial fibroblasts | Src inhibition prevented activation of signaling pathways including TGF- β1, EGFR and STAT3, ameliorating renal fibrosis | Yan et al. (2016) |
| 11 | Mice model | Unilateral ureteral obstruction resulting in renal fibrosis | Decreased renal fibrosis was found in Fyn-deficient mice, by inhibition of phosphor-STAT3 | Seo et al. (2016) |
| 12 | Murine model | Administration of CCN2 with EGFR blockade | Decreased fibrotic response in kidney | Rayego-Mateos et al. (2018a) |
| 13 | Mice model | Ang II with endothelial HB-EGF deletion | Compared with controls, decreased EGFR activation and diminished renal fibrosis | Zeng et al. (2016) |
| 14 | Mouse model | Using a Smad3-dependent mechanism, Erbb4-IR induced by TGF-β1 was silenced | Reduced renal fibrosis along with blockage of collagen I and α-SMA expressions that are TGF-β1-induced in vitro | Feng et al. (2018) |
| 15 | Mouse model | Silencing Erbb4-IR induced by T2DN | Protecting the kidney in db/db mice models from progressive renal injury due to amplified miR-29b | Sun et al. (2018) |
| 16 | Mice model | Tempol-treated CKD mice | TGF-ß/Smad3-induced renal fibrosis along with EGFR/MAPK pathways activation was inhibited | Ding et al. (2015) |
| 17 | Mice model | ADAM17 lacking Ang II-infused mice | In vivo transient protective effects from renal fibrosis | Shen et al. (2017) |
| 18 | Murine model | HDAC 1 blockage in unilateral ureteral obstruction mice | Modulation of TGF-beta and EGFR signaling resulted in amelioration of renal fibrosis and inhibition of the activation of renal fibroblasts | Liu et al. (2013) |
| 19 | Mouse model | HDAC 3 blockage in renal interstitial fibrosis model of obstructive nephropathy | Attenuation of renal interstitial fibrosis | Ponnusamy et al. (2014) |
| 20 | C57BL/6J mice | Expressing of EGFR along with HUWE1 in a UUO mice model | HUWE1 regulated EGFR expression and resulted in a protective effect against kidney injury | Zhu, Q et al. (2020) |
| 21 | C57BL/6 mice | Renal fibrosis generated by a UUO and adenine diet (AD) investigating SAMiRNA-AREG effect on the disease | SAMiRNA-AREG suppressed EGFR signals and is considered as a new siRNA treatment for renal fibrosis | Son et al. (2021) |